3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma
3
Triple Negative Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
1
Pancreatic Neoplasms
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Liver Neoplasms
1
Fibrolamellar hepatocellular carcinoma
1
Diabetes Mellitus, Insulin-Dependent, 12
1
Breast Neoplasms
1
Biliary Tract Neoplasms
1
Interventions
pembrolizumab
17
Bevacizumab
12
Standard of Care
10
Cyclophosphamide
9
Carboplatin
9
Doxorubicin
7
Cetuximab
7
Nivolumab
6
Exercise
6
olaparib
5
atezolizumab
5
Rituximab
5
Radiotherapy
5
Pemetrexed
5
Fluorouracil
5
Cisplatin
5
durvalumab
4
dostarlimab
4
abemaciclib
4
Temozolomide
4
Prednisone
4
Paclitaxel
4
Leucovorin
4
Blood Specimen Collection
4
venetoclax
3
temsirolimus
3
talazoparib
3
pertuzumab
3
obinutuzumab
3
ibrutinib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms
×
poly ICLC
×
30 days
×
Clear all
No trials found.